HIV destroys the immune system by killing CD4 T cells, the white blood cells that coordinate your body’s defense against infections. A healthy adult carries between 500 and 1,200 CD4 cells per cubic millimeter of blood. Without treatment, HIV steadily drains that supply over years, eventually leaving the body unable to fight off infections that a working immune system would easily handle.
But the damage goes well beyond simply killing infected cells. HIV triggers a chain of events, from massive early losses in the gut to chronic bodywide inflammation, that weakens immunity in ways that persist even after treatment begins.
How the Virus Gets Inside Immune Cells
HIV targets CD4 T cells because it literally uses them as a doorway. The virus carries a surface protein that locks onto the CD4 receptor on the outside of these cells. Cryo-electron imaging has revealed this happens in steps: the virus first attaches to a single CD4 molecule, then recruits a second and third as it pulls itself closer to the cell membrane. Once three CD4 molecules are engaged, the viral envelope shifts into an open state that allows the virus to fuse with the cell and inject its genetic material inside.
After entry, HIV hijacks the cell’s own machinery to make copies of itself. Those copies burst out to infect more CD4 cells, and the cycle accelerates. This is why CD4 counts drop: the very cells responsible for organizing immune responses become virus-producing factories.
The Gut Takes the First Major Hit
The earliest and most dramatic damage happens in the gut lining, not in the bloodstream. During the first weeks of infection, more than 50% of CD4 T cells in the gastrointestinal tract are wiped out. The gut holds a huge proportion of the body’s immune tissue, and CD4 cells there are especially vulnerable because many are in the activated state HIV prefers to infect.
This early gut depletion has lasting consequences. The intestinal barrier depends on immune surveillance to stay intact. When that surveillance collapses, bacterial products can leak from the gut into the bloodstream, fueling the chronic inflammation that becomes a hallmark of untreated HIV.
Most CD4 Cells Die Without Ever Being Infected
One of the more surprising findings about HIV is that the virus doesn’t need to fully infect a cell to kill it. Only a small fraction of CD4 cells die from productive infection, where the virus completes its life cycle and the cell is destroyed in the process. More than 95% of CD4 T cells that die during HIV infection are actually bystanders. These are resting cells in lymph tissue where the virus attempts to infect them but fails partway through, leaving fragments of viral DNA floating in the cell’s interior.
The cell detects those DNA fragments as a threat and triggers a self-destruct program called pyroptosis. Unlike quiet cell death, pyroptosis is violently inflammatory. The dying cell bursts open, spilling its contents and inflammatory signaling molecules into the surrounding tissue. Those signals attract more CD4 cells to the area, which then become targets themselves. This creates a vicious cycle: cell death draws in new cells, which die the same way, which draws in more cells. It is this cycle, not direct viral killing, that accounts for the bulk of CD4 loss.
Chronic Inflammation That Never Switches Off
HIV infection triggers persistent, bodywide inflammation that continues for as long as the virus is active, and in many cases lingers even after treatment suppresses the virus to undetectable levels. Inflammatory signaling molecules, particularly those involved in activating immune cells and altering fat metabolism, remain elevated in a large proportion of people living with HIV. Studies of treated patients with stable CD4 counts still show higher levels of these inflammatory markers compared to people without HIV.
This matters because chronic inflammation isn’t just an abstract lab finding. It drives real health consequences. Activated immune cells pour out signals that affect blood vessels, the liver, and fat tissue. The result is a measurably higher risk of cardiovascular disease, even in people whose virus is well controlled. Inflammation also exhausts the immune system over time, aging it prematurely so that immune cells become less effective at responding to new threats.
How the Virus Hides From the Immune System
HIV has a built-in survival strategy that makes it extraordinarily difficult to eliminate. When an actively infected CD4 T cell transitions back to a resting state, the viral DNA already woven into the cell’s chromosomes goes silent. The cell stops producing virus, and because it no longer displays viral proteins on its surface, the immune system can’t distinguish it from any other healthy resting cell.
These silently infected cells form what’s known as a latent reservoir. They can persist for decades, occasionally reactivating and seeding new rounds of infection if treatment is interrupted. The infected cells also remain mobile, traveling through tissues and spreading the reservoir throughout the body. This is the primary reason HIV cannot currently be cured by antiretroviral therapy alone: the drugs suppress active viral replication but cannot reach or clear virus hiding inside resting cells.
Collateral Damage to Other Immune Cells
HIV’s effects extend beyond CD4 T cells. B cells, the immune cells responsible for producing antibodies, become hyperactivated as an indirect consequence of ongoing viral replication. Instead of generating targeted, effective antibodies against specific threats, hyperactivated B cells produce large quantities of nonspecific antibodies that aren’t particularly useful. Over time, this exhausts the B cell population and weakens the body’s ability to mount a proper antibody response to new infections or vaccines.
CD8 T cells, which normally kill virus-infected cells, also suffer. They become chronically activated from trying to control HIV and gradually lose their effectiveness, a state immunologists call exhaustion. The net result is an immune system that’s simultaneously overworked and underperforming.
What Happens as CD4 Counts Fall
The practical consequence of CD4 depletion is increasing vulnerability to infections that healthy immune systems suppress without effort. The risks follow a rough staircase pattern tied to CD4 count:
- Below 200 cells/mm³: This is the threshold for an AIDS diagnosis. Pneumocystis pneumonia, a fungal lung infection, becomes a serious risk. Certain parasitic infections also become common at this level.
- Below 100 cells/mm³: The risk of toxoplasmosis (a parasitic brain infection) and other fungal infections rises sharply.
- Below 50 cells/mm³: Infections caused by bacteria that normally live harmlessly in the environment, such as Mycobacterium avium complex, can become life-threatening.
These infections are called opportunistic because they exploit the gap left by a depleted immune system. In a person with a normal CD4 count, the same organisms are easily held in check.
How Treatment Reverses the Damage
Antiretroviral therapy stops HIV from replicating, which allows CD4 counts to recover. The steepest rebound happens in the first three months of treatment, but counts continue to climb for at least 10 years with consistent use. People who start treatment with very low CD4 counts or very high viral loads often see the fastest rate of recovery, likely because there’s more ground to regain.
Several factors influence how well CD4 counts recover. Younger age, higher body weight at the start of treatment, and female sex are all associated with better recovery rates. Starting treatment early, before CD4 counts fall dramatically, generally leads to more complete immune restoration.
Recovery has limits, though. The gut damage from early infection may never fully reverse, and the latent reservoir persists indefinitely. Chronic inflammation often continues at lower levels even with full viral suppression. This is why people on long-term treatment can still face elevated risks of heart disease and other inflammatory conditions compared to the general population. Treatment transforms HIV from a progressive, fatal disease into a manageable chronic condition, but the immune system rarely returns to a completely pre-infection state.